| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-10 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-08 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-07 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-07 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-06 |